Birgitta Versluijs

176 in the Setting of Total Body Irradiation- Based Myeloablative Conditioning. In- ternational journal of radiation oncolo- gy, biology, physics. 2016;94(2):349-59. 15. Sakaguchi H, Takahashi Y, Watanabe N, Doisaki S, Muramatsu H, Hama A, et al. Incidence, clinical features, and risk fac- tors of idiopathic pneumonia syndrome following hematopoietic stem cell trans- plantation in children. Pediatric blood & cancer. 2012;58(5):780-4. 16. Gassas A, Schechter T, Krueger J, Craig- Barnes H, Sung L, Ali M, et al. Serum Krebs Von Den Lungen-6 as a Biomar- ker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Un- dergoing Allogeneic Stem Cell Trans- plantation. Biol Blood Marrow Trans- plant. 2015;21(8):1524-8. 17. Gassas A, Krueger J, Zaidman I, Schech- ter T, Craig-Barnes H, Ali M, et al. Infec- tions and neutrophils in the pathogene- sis of bronchiolitis obliterans syndrome in children after allogeneic stem cell transplantation. Pediatric transplanta- tion. 2016;20(2):303-6. 18. Prais D, Sinik MM, Stein J, Mei-Zahav M, Mussaffi H, Steuer G, et al. Effec- tiveness of long-term routine pulmo- nary function surveillance following pediatric hematopoietic stem cell transplantation. Pediatric pulmonology. 2014;49(11):1124-32. 19. Quigg TC, Kim YJ, Goebel WS, Haut PR. Lung function before and after pe- diatric allogeneic hematopoietic stem cell transplantation: a predictive role for DLCOa/VA. J Pediatr Hematol Oncol. 2012;34(4):304-9. 20. Srinivasan A, Srinivasan S, Sunthankar S, Sunkara A, Kang G, Stokes DC, et al. Pre-hematopoietic stem cell transplant lung function and pulmonary complica- tions in children. Annals of the Ameri- can Thoracic Society. 2014;11(10):1576- 85. 21. Uhlving HH, Bang CL, Christensen IJ, Buchvald F, Nielsen KG, Heilmann CJ, et al. Lung function after allogeneic he- matopoietic stem cell transplantation in children: a longitudinal study in a popu- lation-based cohort. Biol Blood Marrow Transplant. 2013;19(9):1348-54. 22. Hachem RR. Acute Rejection and Antibody-Mediated Rejection in Lung Transplantation. Clin Chest Med. 2017;38(4):667-75. 23. Verleden SE, Sacreas A, Vos R, Vanaude- naerde BM, Verleden GM. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation. Chest. 2016;150(1):219-25. 24. Kumar D, Husain S, Chen MH, Mous- sa G, Himsworth D, Manuel O, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplan- tation. 2010;89(8):1028-33. 25. Chemaly RF, Shah DP, Boeckh MJ. Ma- nagement of respiratory viral infections in hematopoietic cell transplant reci- pients and patients with hematologic malignancies. Clin Infect Dis. 2014;59 Suppl 5:S344-51. 26. Green ML. Viral Pneumonia in Patients with Hematopoietic Cell Transplantati- on and Hematologic Malignancies. Clin Chest Med. 2017;38(2):295-305. 27. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infec- tions in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainflu- enza virus, metapneumovirus, rhino- virus, and coronavirus. Clin Infect Dis. 2013;56(2):258-66. 28. Seo S, Waghmare A, Scott EM, Xie H, Kuypers JM, Hackman RC, et al. Human rhinovirus detection in the lower respiratory tract of hematopoie- References 9